Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.225 USD | +0.12% | +15.67% | +14.43% |
05-10 | Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating | MT |
05-10 | Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
480M | - | |||||
111B | ||||||
106B | ||||||
22.24B | - | |||||
21.25B | - | |||||
18.97B |